The Headlines – Weight-loss therapy set to push pharma growth

India’s obesity drug market is booming, poised for significant growth driven by rising lifestyle diseases and upcoming affordable generics. Experts anticipate wider access to GLP-1 medicines, accelerating innovation through AI, and a shift towards complex generics. This transformative phase promises improved patient outcomes and positions India as a key player in global healthcare advancements.

The Headlines – Business News Today: Stock Markets, Financial News, India Business & World Business News – Read More